Cargando…
ABO blood group in Malagasy patients with cancer: which group predominates?
The blood group of Malagasy patients with cancer have never been the subject of previous publications. Our objective was to determine the blood group of Malagasy patients with cancer followed in the Medical Oncology Unit of the Soavinandriana Teaching Hospital, Antananarivo. This was a one-year retr...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The African Field Epidemiology Network
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560947/ https://www.ncbi.nlm.nih.gov/pubmed/31223364 http://dx.doi.org/10.11604/pamj.2019.32.73.17994 |
_version_ | 1783426055877427200 |
---|---|
author | Hasiniatsy, Nomeharisoa Rodrigue Emile Batavisoaniatsy, Elodie Emile Refeno, Valéry Andriambololona, Mamy Ramahandrisoa, Andriatsihoarana Voahary Nasandratriniavo Rafaramino, Florine |
author_facet | Hasiniatsy, Nomeharisoa Rodrigue Emile Batavisoaniatsy, Elodie Emile Refeno, Valéry Andriambololona, Mamy Ramahandrisoa, Andriatsihoarana Voahary Nasandratriniavo Rafaramino, Florine |
author_sort | Hasiniatsy, Nomeharisoa Rodrigue Emile |
collection | PubMed |
description | The blood group of Malagasy patients with cancer have never been the subject of previous publications. Our objective was to determine the blood group of Malagasy patients with cancer followed in the Medical Oncology Unit of the Soavinandriana Teaching Hospital, Antananarivo. This was a one-year retrospective study (November 2012 to October 2013) in patients over the age of 15 with histological or pathological evidence of their cancer. One hundred and thirty of the 258 patients identified had an ABO blood group determination (50.39%). Among these 130 patients, 114 patients (87.69%) had solid tumors and 16 patients (12.31%) had hematologic malignancies. Thirty seven (28.49%) patients were transfused and 93 (71.54%) not transfused. There were 57 men and 73 women (sex ratio = 0.78), the average age was 55.11 +/- 14.76 years. With regard to their blood group, 52 patients (40%) were blood group B, 44 (33.84%) group O, 27 (20.76%) group A and 7 (5.38%) group AB. The order of blood group frequency of cancer patients in our series differs from other studies. This study has allowed us to know the proportion of each blood group in our Unit and thus help us in the management of stocks of labile blood products in our hospital. |
format | Online Article Text |
id | pubmed-6560947 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The African Field Epidemiology Network |
record_format | MEDLINE/PubMed |
spelling | pubmed-65609472019-06-20 ABO blood group in Malagasy patients with cancer: which group predominates? Hasiniatsy, Nomeharisoa Rodrigue Emile Batavisoaniatsy, Elodie Emile Refeno, Valéry Andriambololona, Mamy Ramahandrisoa, Andriatsihoarana Voahary Nasandratriniavo Rafaramino, Florine Pan Afr Med J Letter to the Editors The blood group of Malagasy patients with cancer have never been the subject of previous publications. Our objective was to determine the blood group of Malagasy patients with cancer followed in the Medical Oncology Unit of the Soavinandriana Teaching Hospital, Antananarivo. This was a one-year retrospective study (November 2012 to October 2013) in patients over the age of 15 with histological or pathological evidence of their cancer. One hundred and thirty of the 258 patients identified had an ABO blood group determination (50.39%). Among these 130 patients, 114 patients (87.69%) had solid tumors and 16 patients (12.31%) had hematologic malignancies. Thirty seven (28.49%) patients were transfused and 93 (71.54%) not transfused. There were 57 men and 73 women (sex ratio = 0.78), the average age was 55.11 +/- 14.76 years. With regard to their blood group, 52 patients (40%) were blood group B, 44 (33.84%) group O, 27 (20.76%) group A and 7 (5.38%) group AB. The order of blood group frequency of cancer patients in our series differs from other studies. This study has allowed us to know the proportion of each blood group in our Unit and thus help us in the management of stocks of labile blood products in our hospital. The African Field Epidemiology Network 2019-02-12 /pmc/articles/PMC6560947/ /pubmed/31223364 http://dx.doi.org/10.11604/pamj.2019.32.73.17994 Text en © Nomeharisoa Rodrigue Emile Hasiniatsy et al. http://creativecommons.org/licenses/by/2.0/ The Pan African Medical Journal - ISSN 1937-8688. This is an Open Access article distributed under the terms of the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Letter to the Editors Hasiniatsy, Nomeharisoa Rodrigue Emile Batavisoaniatsy, Elodie Emile Refeno, Valéry Andriambololona, Mamy Ramahandrisoa, Andriatsihoarana Voahary Nasandratriniavo Rafaramino, Florine ABO blood group in Malagasy patients with cancer: which group predominates? |
title | ABO blood group in Malagasy patients with cancer: which group predominates? |
title_full | ABO blood group in Malagasy patients with cancer: which group predominates? |
title_fullStr | ABO blood group in Malagasy patients with cancer: which group predominates? |
title_full_unstemmed | ABO blood group in Malagasy patients with cancer: which group predominates? |
title_short | ABO blood group in Malagasy patients with cancer: which group predominates? |
title_sort | abo blood group in malagasy patients with cancer: which group predominates? |
topic | Letter to the Editors |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6560947/ https://www.ncbi.nlm.nih.gov/pubmed/31223364 http://dx.doi.org/10.11604/pamj.2019.32.73.17994 |
work_keys_str_mv | AT hasiniatsynomeharisoarodrigueemile abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates AT batavisoaniatsyelodieemile abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates AT refenovalery abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates AT andriambololonamamy abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates AT ramahandrisoaandriatsihoaranavoaharynasandratriniavo abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates AT rafaraminoflorine abobloodgroupinmalagasypatientswithcancerwhichgrouppredominates |